JPMORGAN CHASE & CO - INSMED INC ownership

INSMED INC's ticker is and the CUSIP is 457669AB5. A total of 49 filers reported holding INSMED INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of INSMED INC
ValueSharesWeighting
Q3 2023$1,316,864
+1645.2%
1,326,000
+1389.9%
0.00%
Q2 2023$75,457
-93.6%
89,000
-94.2%
0.00%
Q1 2023$1,188,000
+55544.0%
1,526,000
-40.6%
0.00%
Q4 2022$2,135
-99.9%
2,570,000
+21.9%
0.00%
Q3 2022$1,908,000
-28.1%
2,109,000
-35.6%
0.00%
Q2 2022$2,652,000
+31.9%
3,274,000
+76.7%
0.00%
Q4 2021$2,010,0001,853,0000.00%
Other shareholders
INSMED INC shareholders Q2 2022
NameSharesValueWeighting ↓
Sycale Advisors (NY) LLC 10,475,000$9,487,0003.75%
LITTLEJOHN & CO LLC 40,000$3,666,0001.90%
Saltoro Capital, LP 3,000,000$2,750,0001.12%
ABSOLUTE INVESTMENT ADVISERS, LLC 6,380,000$5,806,0001.03%
SSI INVESTMENT MANAGEMENT LLC 8,749,000$7,931,0000.53%
WOLVERINE ASSET MANAGEMENT LLC 52,586,000$47,808,0000.52%
CAPSTONE INVESTMENT ADVISORS, LLC 66,377,000$60,835,0000.37%
Baker Brothers Advisors 40,000,000$36,296,0000.24%
LORD, ABBETT & CO. LLC 41,987,000$38,482,0000.14%
AVIVA PLC 25,000,000$22,675,0000.13%
View complete list of INSMED INC shareholders